Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with bulimia nervosa
- PMID: 10971457
- DOI: 10.1046/j.1365-2265.2000.01091.x
Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with bulimia nervosa
Abstract
Background: Tumor necrosis factor-alpha (TNF-alpha) is a cytokine with numerous immunological and metabolic activities. In addition, TNF-alpha can stimulate a variety of physiological, neuroendocrine and behavioural responses of the central nervous system. In experimental animals, TNF-alpha induces changes in physiological and behavioural parameters which have also been observed in eating disorders. The biological activities of TNF-alpha are mediated by two structurally related, but functionally distinct receptors, TNF-RI and TNF-RII. Since injection of TNF-alpha results in increased shedding of TNF-alpha receptors, it is likely that TNF-alpha release is reflected by soluble TNF-receptors (sTNF-Rs) levels.
Aims: We studied plasma concentrations of TNF-alpha and two sTNF-Rs (sTNF-RI and sTNF-RII) in female patients with bulimia nervosa.
Design and patients: Twenty female patients with bulimia nervosa (BN) and 20 age-matched normal women (N) were studied.
Measurements: Plasma TNF-alpha concentrations were measured by enzyme immunoassay kit and plasma concentrations of sTNF-RI and sTNF-RII were measured by enzyme-linked immunosorbent assay.
Results: Plasma TNF-alpha concentrations in BN were significantly higher than those in N (4.7+/- 0.5 ng/l vs. 1.6+/-0.1 ng/l; P<0.01). Although no significant difference was observed in plasma sTNF-RI concentrations between the two groups, plasma sTNF-RII concentrations in BN were significantly higher than those in N (2080.0+/-107.5 ng/l vs. 1569.5 +/-84.0 ng/l; P<0.01). Plasma TNF-alpha concentrations were significantly related to plasma sTNF-RI concentrations (r = 0.511, P<0.05) and to plasma sTNF-RII concentrations (r = 0.532, P<0.05) in bulimic patients. However, plasma TNF-alpha concentrations were not related to body fat mass or to bulimic behaviours in these patients.
Conclusions: Our present findings suggest that the adipose tissue may not be the immediate source of TNF-alpha in bulimic patients but the increase in plasma TNF-alpha in these patients may be derived from the central nervous system sources. The elevated sTNF-RII may reflect different shedding kinetics compared with sTNF-RI in bulimic patients.
Similar articles
-
Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis.Clin Endocrinol (Oxf). 2002 Dec;57(6):805-11. doi: 10.1046/j.1365-2265.2002.01672.x. Clin Endocrinol (Oxf). 2002. PMID: 12460331
-
Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with anorexia nervosa.J Clin Endocrinol Metab. 1999 Apr;84(4):1226-8. doi: 10.1210/jcem.84.4.5589. J Clin Endocrinol Metab. 1999. PMID: 10199758
-
Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure.Jpn Circ J. 1997 Aug;61(8):657-64. doi: 10.1253/jcj.61.657. Jpn Circ J. 1997. PMID: 9276770
-
PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases.Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I73-81. doi: 10.1136/ard.58.2008.i73. Ann Rheum Dis. 1999. PMID: 10577978 Free PMC article. Review.
-
Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis.Eur J Haematol. 1995 Jan;54(1):1-8. doi: 10.1111/j.1600-0609.1995.tb01618.x. Eur J Haematol. 1995. PMID: 7859870 Review.
Cited by
-
Longitudinal associations between circulating interleukin-6 and C-reactive protein in childhood, and eating disorders and disordered eating in adolescence.Brain Behav Immun. 2020 Oct;89:491-500. doi: 10.1016/j.bbi.2020.07.040. Epub 2020 Aug 2. Brain Behav Immun. 2020. PMID: 32755646 Free PMC article. Review.
-
The Role of the Gut Microbiome, Immunity, and Neuroinflammation in the Pathophysiology of Eating Disorders.Nutrients. 2021 Feb 3;13(2):500. doi: 10.3390/nu13020500. Nutrients. 2021. PMID: 33546416 Free PMC article. Review.
-
Gut hormones, adipokines, and pro- and anti-inflammatory cytokines/markers in loss of control eating: A scoping review.Appetite. 2021 Nov 1;166:105442. doi: 10.1016/j.appet.2021.105442. Epub 2021 Jun 8. Appetite. 2021. PMID: 34111480 Free PMC article.
-
Elevated interleukin-6 in women with binge-eating spectrum disorders.Int J Eat Disord. 2024 Jul;57(7):1510-1517. doi: 10.1002/eat.24183. Epub 2024 Mar 6. Int J Eat Disord. 2024. PMID: 38445571 Free PMC article.
-
Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Bulimia Nervosa (BN): A Review and Insight into Potential Mechanisms of Action.J Clin Med. 2024 Sep 10;13(18):5364. doi: 10.3390/jcm13185364. J Clin Med. 2024. PMID: 39336850 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous